| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/12/2007 | EP1641797B1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo[2,3-d]pyrimidine hydrogen mesylate and its polymorphic forms |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1519925B1 Oxazole derivatives and their use as insulin sensitizers |
| 09/12/2007 | EP1498118B1 Patch and process for producing the same |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP1268305B1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | EP0751926B1 Enhancement of the efficacy of drugs by deuteration |
| 09/12/2007 | CN101035891A Lecithinized superoxide dismutase composition and process for producing the same |
| 09/12/2007 | CN101035761A 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt |
| 09/12/2007 | CN101035548A Steroidal saponin pharmaceutical composition, the preparation method and use thereof |
| 09/12/2007 | CN101035545A Pulmonary administration of an antithrombotic compound |
| 09/12/2007 | CN101035543A Combination therapies employing vitamin B6 related compounds and ACE inhibitors and uses thereof for the treatment of diabetic disorders |
| 09/12/2007 | CN101035539A Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 09/12/2007 | CN101035530A VEGF inhibition |
| 09/12/2007 | CN101035433A Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 09/12/2007 | CN101033255A Fusion protein of P11 and SAK and its preparation method and use |
| 09/12/2007 | CN101033245A Preparation method and application of pedunculoside |
| 09/12/2007 | CN101032619A Liquid medicine to be taken orally for curing primary hypertension and the preparing method |
| 09/12/2007 | CN101032602A Tianxiang capsule for releasing pressure |
| 09/12/2007 | CN101032595A Energy source capsule and the preparing method |
| 09/12/2007 | CN101032575A Chinese traditional medicine for curing angiocardiopathy and cerebrovascular disease |
| 09/12/2007 | CN101032574A Chinese medicine composition for treating hypertension |
| 09/12/2007 | CN101032572A Sanguisorba huaijiao agent and the novel preparing method |
| 09/12/2007 | CN101032562A Health care product having functions of conditioning blood pressure and protecting haemal system of heart and brain |
| 09/12/2007 | CN101032557A Fupian granulae and the preparing method |
| 09/12/2007 | CN101032554A Medicine for curing frequently encountered disease caused by Huohan toxicum and the preparing method |
| 09/12/2007 | CN101032537A Gynura procumbens (Lour.) Merr. Flavonoid substances preparing method and the application |
| 09/12/2007 | CN101032534A Method of preparing jiubiying total saponins and the application thereof |
| 09/12/2007 | CN101032533A Method of preparing solution / substance extracted from ginkgo leaves |
| 09/12/2007 | CN101032532A Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof |
| 09/12/2007 | CN101032506A Chinese traditional medicine composition for hemangiectasis |
| 09/12/2007 | CN101032505A Treatment medicine and healthy product including liquiritin |
| 09/12/2007 | CN101032504A Application of liquiritin in medicines |
| 09/12/2007 | CN101032503A Effective elements of Chinese traditional medicine combination for curing cardiovascular disease and the quality control method |
| 09/12/2007 | CN101032501A Application of centella triterpenes in the preparing of medicine for preventing and curing cardiac muscle fibrosis |
| 09/12/2007 | CN101032495A Application of Asiatic Acid in the preparing of medicine for preventing and curing cardiac muscle pancreatic fibrosis |
| 09/12/2007 | CN101032491A Benazepril pharmaceutical compsn. and process for its prepn. |
| 09/12/2007 | CN101032482A Compound preparation resisting coxsackie virus and herpesvirus |
| 09/12/2007 | CN101032477A Electrolyte complementary medical combination for injection |
| 09/12/2007 | CN101032476A Medical combination including rhein or diacetylrhein and the preparing method thereof |
| 09/12/2007 | CN101032473A Sandwich type medical releasing film and preparing method thereof |
| 09/12/2007 | CN101032464A Combination containing rimonabant and polyvinyl pyrrolidone, solid dispersion and the preparing and medicine application thereof |
| 09/12/2007 | CN101032462A Mexiletine Hydrochloride slow release reagent and preparing method thereof |
| 09/12/2007 | CN101032325A Anti-hypertensive health products |
| 09/12/2007 | CN101032271A Gingko coffee |
| 09/12/2007 | CN101032270A Preparing method of composite type persimmon leaf tea |
| 09/12/2007 | CN101032269A Compound bag-soak-tea |
| 09/12/2007 | CN100336554C Chinese herbal plant medicinal oil |
| 09/12/2007 | CN100336549C Medication for treating hemorrhoid, and preparation method |
| 09/12/2007 | CN100336547C Medicine for treating high blood pressure disease |
| 09/12/2007 | CN100336545C Medicinal wine with aizoon stonecrop for treating blood vessel disease and its preparation method |
| 09/12/2007 | CN100336534C Medicine for treating coronary heart disease and its preparation method |
| 09/12/2007 | CN100336530C Process for preparing plaster to treat hypertension |
| 09/12/2007 | CN100336528C Chinese medicinal preparation for treating high blood pressure and high blood fat |
| 09/12/2007 | CN100336524C Method for preparing extract product of paeoniflorin |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 09/12/2007 | CN100336519C Snakegourd peel lyophilized powder injection and its preparation process |
| 09/12/2007 | CN100336516C Ginkgo leaf extract and dipyridamole compound medicine and its preparing method |
| 09/12/2007 | CN100336513C Pharmaceutical preparation ingested via nose for treating ischemia cerebrovascular disease |
| 09/12/2007 | CN100336507C Nimoldipine new nano liposome, its precursor freeze dryed matter and its preparing method |
| 09/12/2007 | CN100336505C Soybean aglycone soft capsule and its preparing method |
| 09/12/2007 | CN100336504C Beta-Asarone transdermal plaster |
| 09/12/2007 | CN100336458C Health-preserving preserved gastrodia tuber for middle aged and old aged people |
| 09/11/2007 | US7268230 Quinazoline compounds |
| 09/11/2007 | US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 09/11/2007 | US7268160 A therapeutic or prophylactic agent for a disease that requires enhancement of nerve growth factor production, e.g., butein; nervous system disorders; Alzeimher's disease; additive for foods, beverages and feeds |
| 09/11/2007 | US7268156 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268145 Thiobenzimidazole derivatives |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268129 Fluorinated benzothiadiazine compounds |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | US7267973 Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2201652C Use of purified sdg as an antioxidant |
| 09/11/2007 | CA2188931C Agent for treating cor pulmonale |
| 09/07/2007 | WO2007100566A2 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | WO2007100295A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors |
| 09/07/2007 | WO2007100103A1 Ameliorating agent for metabolic syndrome |
| 09/07/2007 | WO2007100027A1 Optically active thiazolidinedione derivative |
| 09/07/2007 | WO2007099345A1 Medical use of bmp-2 and/ or bmp-4 |
| 09/07/2007 | WO2007099166A1 Pyrazolo-pyridine derivatives active as kinase inhibitors |
| 09/07/2007 | WO2007099151A1 Methods and agents for reducing oxidative stress |
| 09/07/2007 | WO2007099070A1 Treatment of prevention of valvular heart disease with flibanserin |
| 09/07/2007 | WO2007098520A1 Process for the manufacture of a composition containing at least one xanthophyll |
| 09/07/2007 | WO2007084857A3 Methods and compositions for treating cell proliferative disorders |
| 09/07/2007 | WO2007077329A3 New association of a sinus current if inhibitor and a calcic inhibitor, and pharmaceutical compositions containing the same |
| 09/07/2007 | WO2007071733A3 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |